Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

At the heart of the Medical Sciences Division graduate student community is the annual DPhil Day – a one day event, which brings together DPhil students from all 16 departments, to showcase the breadth and depth of basic and clinical research taking place across the Division.

© MSD

This year’s event attracted more abstracts than ever before, with 60 students presenting posters and 12 more giving talks to over 150 attendees.

Congratulations to David Nasralla from the Nuffield Department of Surgical Sciences who was the winner of the oral presentation prize, along with Kezia Gaitskell. The title of his presentation was 'A Multinational Randomised Controlled Trial Comparing Normothermic Machine Perfusion with Statc Cold Storage in Human Liver Transplantation: Early Outcomes.'

David presented the preliminary results from the first trial in human to compare normothermic liver preservation with conventional cold storage techniques. This EU-funded trial was conducted in England, Belgium, Germany and Spain, and sponsored by Oxford University. The results show a convincing improvement in early graft function following liver transplantation of normothermic preserved livers. The team are now awaiting the longer term follow-up data which will include MRCP information about ischaemic cholangiopathy.

Read the organising committee's report of the day.

Similar stories

ASPI honours ProtecT Trial for pioneering research demonstrating the safety of active surveillance

The ProtecT Trial has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award for game-changing research in the development of the Active Surveillance approach to managing low-risk prostate cancer.